From NAFLD in clinical practice to answers from guidelines - Test2 - elhamkhani - TriplyDB

From NAFLD in clinical practice to answers from guidelines

From NAFLD in clinical practice to answers from guidelines

http://www.wikidata.org/entity/Q27000185

about

Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the Spotlight Relationship between Non-Alcoholic Fatty Liver Disease and Psoriasis: A Novel Hepato-Dermal Axis?Part 2: Treatments for Chronic Gastrointestinal Disease and Gut Dysbiosis Chemoprevention of obesity-related liver carcinogenesis by using pharmaceutical and nutraceutical agents Treatment of Nonalcoholic Fatty Liver Disease: The Role of Medical, Surgical, and Endoscopic Weight Loss The role of dietary sugars and de novo lipogenesis in non-alcoholic fatty liver disease Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat Using a New Quantitative Ultrasound Technique Metabolic aspects of adult patients with nonalcoholic fatty liver disease Transient elastography (FibroScan(®)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV Neck circumference, along with other anthropometric indices, has an independent and additional contribution in predicting fatty liver disease Prevalence of fatty liver disease and the economy in China: A systematic review Treatment of nonalcoholic fatty liver disease: role of AMPK.Cost-utility analysis of nonalcoholic steatohepatitis screening.Liver fibrosis markers of nonalcoholic steatohepatitis.Controversies in the Diagnosis and Management of NAFLD and NASH.Association of Non-alcoholic Fatty Liver Disease with Conduction Defects on Electrocardiogram.Non-Alcoholic Fatty Liver Disease Association with Cardiac Arrhythmias Non-alcoholic fatty liver disease: An expanded review Cathepsin D regulates lipid metabolism in murine steatohepatitis.NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk.Nonalcoholic fatty liver disease and aging: epidemiology to management.The influence of dietary fat on liver fat accumulation.Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet.Serum amylase levels are decreased in Chinese non-alcoholic fatty liver disease patients Serum cytokeratin 18 fragment level as a noninvasive biomarker for non-alcoholic fatty liver disease From whole body to cellular models of hepatic triglyceride metabolism: man has got to know his limitations Characteristics of hepatocellular carcinoma in cirrhotic and non-cirrhotic non-alcoholic fatty liver disease.Recent advances in dietary supplementation, in treating non-alcoholic fatty liver disease.External validation of fatty liver index for identifying ultrasonographic fatty liver in a large-scale cross-sectional study in Taiwan.Interferon gamma-induced protein 10 is associated with insulin resistance and incident diabetes in patients with nonalcoholic fatty liver disease.Dietary Patterns Modulate the Risk of Non-Alcoholic Fatty Liver Disease in Chinese Adults.Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study).Awareness of nonalcoholic steatohepatitis and associated practice patterns of primary care physicians and specialists.Hypolactasia is associated with insulin resistance in nonalcoholic steatohepatitis.From NAFLD to Cardiovascular Disease. Is it (Still) the Metabolic Syndrome?Role of pentoxifylline in non-alcoholic fatty liver disease in high-fat diet-induced obesity in mice.Presence of atrial fibrillation is associated with liver stiffness in an elderly Finnish population.Non-alcoholic fatty liver disease severity, central fat mass and adinopectin: a close relationship Assessment of Diet and Physical Activity in Paediatric Non-Alcoholic Fatty Liver Disease Patients: A United Kingdom Case Control Study.

P2860

Q26752583-80D94735-6098-4A33-B24F-8D301031F921 Q26767276-A918948B-F2A7-42BE-95F0-B602262C37D3 Q26771942-CB90F2A9-70DA-4C52-99BA-78C3F4200FCD Q26772302-355D735A-A034-4725-A9B2-5349EAC21F5F Q26775632-2C17E17A-806B-469D-8C33-37A9EE8D4FC6 Q27016052-6E495466-6052-4D0B-8CD3-36FA46A013AB Q27318751-BA78C97B-B56B-48B5-A310-66F21425F00D Q28067490-8F31CC65-B759-4276-B4E3-2876A5003525 Q28079445-6209EFF7-35F1-4D9A-91D7-CA7E19DA9F67 Q28079826-AC0C1AFE-CAC6-40A0-8BEF-927D6B371481 Q28543519-50889F2A-DBA5-4E1E-AFA1-9A34A24B996B Q28647695-2DBAC53E-ECEA-441E-8AAC-3796F40BF5AF Q30248230-5D217D2C-C77B-451D-B409-BD5B8EBF4276 Q30385602-CC08AF5D-2B56-461F-8253-4085E96BB6E4 Q30407625-1E01E114-1CD1-498B-93AF-4DD3846097E9 Q30412296-CB1587CC-636C-4835-9BB5-92FD16880265 Q33591227-0EF6A992-ED5A-41D2-BFAB-5AF5FF1095BB Q33675914-E3CA771E-2819-42F3-AB68-081022BCA00B Q33789868-F319F0AA-D5EF-482D-8BE2-2A0B328C8DE1 Q33799445-1E33FF31-DC35-4B44-95D1-726714255834 Q33844463-E803ED01-EE80-4375-A3AB-54EB8F5C9F5D Q34366861-36DD2B76-B646-4998-B437-9A06F94E77BC Q34578071-E437ACB1-CD2E-4ACB-B9B1-233FC0220880 Q34647390-531EDF6A-E8E8-4B14-96A0-4EB6584E76F3 Q34709831-67B978D3-4DBE-438D-B600-006B5141D0C2 Q34769910-D8DA5FCA-602E-4FF0-9009-7720415D0AC9 Q34800989-B3A4E5B8-E347-412B-B90B-DA8B4112236F Q35012074-91A98D3D-19E0-4022-8000-01E12A4D2327 Q35127037-0A036A95-675F-4484-A935-77EA22C02D97 Q35188136-F179A29A-6E21-4034-96D8-EC1DDD3ADB05 Q35591165-297D32B0-14D1-400D-9663-5AE6AA79B9F5 Q35809005-CFBE6023-96B5-4024-AD5C-A25BB35FCCC5 Q35841934-4425C51D-EA58-4BE5-8AE8-67F16CBE07FB Q35954671-AAF584DA-80E9-4D3F-989E-C6EC4A5FA14E Q36137908-A300FD98-E346-4C1D-B604-DE8A83236E59 Q36207195-CD0B2ED9-A104-4AA9-AB7A-D2EF772C3D2D Q36209355-E456FE24-A8DA-4541-97EF-C1286741F234 Q36306317-07E07D3F-826D-4C79-B0A5-E09EABB9FD66 Q36398993-5D899655-127B-4682-98D8-74DD426D68CA Q36401194-2B867D1B-8051-4327-9551-BA4E0EEEE087

P2860

From NAFLD in clinical practice to answers from guidelines

http://www.wikidata.org/entity/Q27000185

description

2013 nî lūn-bûn

@nan

2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

From NAFLD in clinical practice to answers from guidelines

@ast

From NAFLD in clinical practice to answers from guidelines

@en

From NAFLD in clinical practice to answers from guidelines

@nl

type

label

From NAFLD in clinical practice to answers from guidelines

@ast

From NAFLD in clinical practice to answers from guidelines

@en

From NAFLD in clinical practice to answers from guidelines

@nl

prefLabel

From NAFLD in clinical practice to answers from guidelines

@ast

From NAFLD in clinical practice to answers from guidelines

@en

From NAFLD in clinical practice to answers from guidelines

@nl

P1433

Q27000185-F0B26476-9C28-4938-B8D9-17ED70ADDD6D

P1476

Q27000185-3EAA0D9D-7274-4814-B9FD-28758CFA192A

P2093

Q27000185-5B3F3E41-1111-4E00-81A0-6C3D2F278198

Q27000185-782591A3-BCF2-47F1-B249-973D644BEB67

Q27000185-7C5EA7B9-9956-4C71-A5E6-0F8B29216027

Q27000185-8C87FBF0-7575-45CE-B706-46284F7F8FBA

Q27000185-904D7214-91CD-4813-A72A-53D199BEDAF5

Q27000185-D05B936A-E924-4C45-B91C-DDB7825D205B

Q27000185-E712BE05-14CC-42A7-9716-126AFDF759C9

P304

Q27000185-9A00DD6B-4B12-491C-A3B8-1315D74E466C

P31

Q27000185-65A31FFE-CB10-4F08-B782-FBB9B9052FAB

P3181

Q27000185-78EA8E66-5CC8-4D5C-8D63-9759F645B5BC

P356

Q27000185-F77DB6D4-D9A7-483A-90F1-BBB18A2A0D8E

P407

Q27000185-EC060B5D-0F79-498F-B194-07ACF79D70BF

P433

Q27000185-640B830D-68EF-4E5B-90F3-5C5E8E1F92A7

P478

Q27000185-91B1E5EA-2559-4F46-8329-CA9B55A3F480

P577

Q27000185-05ECE8DA-151D-4E23-8D3E-63ED2AC3D99F

P5875

Q27000185-53D132E5-DD67-4FF8-8384-5B8416B44C52

P698

Q27000185-6BC1D4A8-DB0B-4990-A727-63E612921F38

P3181

P356

J.JHEP.2013.05.044

P1433

Journal of Hepatology

P1476

From NAFLD in clinical practice to answers from guidelines

@en

P2093

Amedeo Lonardo

http://www.w3.org/2001/XMLSchema#string

Christopher Paul Day

http://www.w3.org/2001/XMLSchema#string

Fabio Nascimbeni

http://www.w3.org/2001/XMLSchema#string

Paola Loria

http://www.w3.org/2001/XMLSchema#string

Raluca Pais

http://www.w3.org/2001/XMLSchema#string

Stefano Bellentani

http://www.w3.org/2001/XMLSchema#string

Vlad Ratziu

http://www.w3.org/2001/XMLSchema#string

P304

859-71

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1147905

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.JHEP.2013.05.044

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

59

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237096355

http://www.w3.org/2001/XMLSchema#string

P698

23751754

http://www.w3.org/2001/XMLSchema#string